Issue 87, 2025

A pillar[5]arene-based polydopamine–prodrug nanoplatform for targeted and synergistic chemodynamic–photothermal–chemotherapy of cancer

Abstract

A targeted nanoplatform was developed by formulating a polydopamine–prodrug conjugate with pillar[5]arene, achieving targeted and synergistic combination of CDT, PTT, and CT.

Graphical abstract: A pillar[5]arene-based polydopamine–prodrug nanoplatform for targeted and synergistic chemodynamic–photothermal–chemotherapy of cancer

Supplementary files

Article information

Article type
Communication
Submitted
09 Sep 2025
Accepted
29 Sep 2025
First published
30 Sep 2025

Chem. Commun., 2025,61, 17041-17044

A pillar[5]arene-based polydopamine–prodrug nanoplatform for targeted and synergistic chemodynamic–photothermal–chemotherapy of cancer

L. Li, F. Zhao, X. Liang, C. Deng, J. Zhang, T. Chen, Y. Wang, J. Wang, Y. Cai and Y. Yao, Chem. Commun., 2025, 61, 17041 DOI: 10.1039/D5CC05197E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements